Periodontal Diseases Clinical Trial
Official title:
A Prospective, Multicenter, Randomized, Blinded and Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Moderate to Severe Generalized Periodontitis
Verified date | March 2023 |
Source | McGuire Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A comparison of laser (REPaiR) compared with minimally invasive surgical therapy for moderate to severe periodontal disease.
Status | Completed |
Enrollment | 54 |
Est. completion date | May 15, 2020 |
Est. primary completion date | May 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Subjects 18 to 75 years of age, inclusive. - Subjects must be diagnosed with moderate to severe generalized periodontitis (ADA Classification Case Type III or IV) as determined by the investigator. - Subjects must have at least one, but up to 2, non-adjacent, qualifying Study Teeth with Pockets (PPD = 6 mm & intrabony vertical = 3 mm, with base of defect = 3 mm coronal to the tooth apex, and defect angle = 25° as defined by radiograph) on non-adjacent teeth. - Subjects will have read, understood and signed an institutional review board (IRB) approved Informed Consent Form (ICF). - Subjects who are able and willing to adhere to the study visit schedule and other protocol requirements. Exclusion Criteria: - Visual inability to identify cementoenamel junction (CEJ) or other landmark for probing measures. - Presence of an acute periodontal abscess at the time of MIST or REPaiR treatment steps - Mobility > 1 at the time of MIST or REPaiR treatment steps - Use of 3rd molars, defects distal to terminal 2nd molars, and teeth treated endodontically as study teeth. - Subjects with healing disorders (such as: diabetes mellitus confirmed HgA1C of > 7 within 6-months of screening, cancer, HIV, bone metabolic diseases or Type IV heart disease) that could compromise wound healing and/ or preclude periodontal surgery; or who are taking medications that compromise wound healing, such as chronic steroid use - either inhaler or systemic, calcium channel blockers with clinical evidence of secondary hyperplastic tissue reactions, anti-seizure medications, medications for bone metabolic diseases, radiation or other immuno-suppressive therapy. - Traumatic occlusion of study teeth not addressed by occlusal adjustment or splint therapy during the course of the study prior to conclusion of SRP - Subjects taking intramuscular or intravenous bisphosphonates. - Subjects smoking >10 cigarettes per day or an equivalent amount of any other nicotine products, such as smokeless chewing tobacco, nicotine patch, vaporizer, gum, pipe, or cigar smoking. - Female subjects who are pregnant or lactating, or who intend to become pregnant during the study duration. - Anticipated use of systemic antibiotics during the trial or within 30 days of SRP - An existing condition that may warrant use of antibiotics during the trial (e.g., ongoing infection noted at Screening Visit, cystic fibrosis or chronic obstructive pulmonary disorder with history of frequent, recurrent lung infections). Use within 30 days prior to Day 1, or a condition for which use is anticipated during trial: topical oral, nasal and systemic corticosteroids. - Anticipated use of the agents known to affect periodontal status during the trial and/or use within 30 days prior to Day 1: immunosuppressants, calcium antagonists or phenytoin- - Participation in another clinical study within 90 days prior to Day 1. - Subjects who received oral health treatments/interventions within 90 days of Day 1, which the investigator believes may interfere with the periodontal parameters to be assessed in this study (e.g., significant dental and/or gum/oral tissue work). - Untreated moderate to severe periodontitis. - Subjects, who in the opinion of the Investigator, for any reason other than those listed above, will not be able to complete the study per protocol |
Country | Name | City | State |
---|---|---|---|
United States | Medelis Inc | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
McGuire Institute | Biolase Inc |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Patient Reported Outcome for Pain | Patient Reported Outcomes (PROs) for Pain Using 10-Point scale 0-"no pain at all" to 10-"pain as bad as you can imagine" VAS. A low score would indicate a low level of patient reported post-operative pain. | Daily for 7-days following Sx | |
Other | Patient Reported Outcome for Satisfaction | Satisfaction with Esthetics and Overall Satisfaction with Procedure Using the following list of response options:
Very satisfied (Scored as 1), Somewhat satisfied (Scored as 2), Neither satisfied nor dissatisfied (Scored as 3), Somewhat dissatisfied (Scored as 4), Very dissatisfied (Scored as 5) A low score would indicate a high level of satisfaction with the treatment provided. |
1-month, 3-months and 6-months post SX | |
Primary | CAL (Clinical Attachment Level) | Clinical Attachment Level Measured by Periodontal Probe using PPD and Recession | 6-months post Sx | |
Secondary | Radiographic evidence of bone fill | Standardized periapical radiographs | 6-months post Sx |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT04478864 -
Knowledge, Practice and State of Periodontal Health
|
||
Completed |
NCT03507868 -
YKL-40 and IL-6 Levels in Periodontal Disease
|
||
Completed |
NCT05720481 -
Impact of Periodontal Treatment on Growth Differentiation Factor-15 Levels
|
N/A | |
Recruiting |
NCT06052150 -
Oral Health In Cirrhosis of the Liver (ORACLE)
|
||
Recruiting |
NCT06025955 -
Evaluation of Outcomes of Minimally Invasive Non- Surgical Versus Surgical Therapy in Furcation Involvement.
|
N/A | |
Recruiting |
NCT03510702 -
SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
|
||
Completed |
NCT05631600 -
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05068778 -
Development of an AI App to Improve Compliance in Periodontal Maintenance Patients
|
||
Not yet recruiting |
NCT05178563 -
Mechanisms of Acute Inflammation Following Periodontal Treatment
|
N/A | |
Recruiting |
NCT06086821 -
Clinical Relevance of Different Time of Periodontal Re-evaluation
|
N/A | |
Recruiting |
NCT06224699 -
Toothpaste With Sodium Carbonate in Patients With Gingivitis
|
N/A | |
Not yet recruiting |
NCT05721313 -
Vital Root Amputation in Molars With Advanced Periodontal Furcation Involvement: a Preliminary Study
|
N/A | |
Completed |
NCT06306937 -
Serum Levels of Vitamin D and IL8 in Patients With Periodontitis
|
||
Completed |
NCT06040944 -
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
|
||
Recruiting |
NCT04669717 -
Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies
|
Phase 4 | |
Completed |
NCT05576142 -
Oral Findings in Pediatric Patients With Allergic Rhinitis and/or Asthma
|
||
Completed |
NCT04017078 -
Assessment of Carotid Artery Calcifications
|
||
Not yet recruiting |
NCT03588507 -
Clinical and Radiographic Evaluation of PPF With or Without NCHA Bone in Treatment of Intrabony Defects
|
N/A |